1.One case of adrenal aldosterone-cortisol co-producing adenoma: clinical analysis and literature review
Zhiying BIAN ; Fei GAO ; Hongyu WANG ; Boyu ZHU ; Yi WANG ; Wenjuan QIU ; Jun AN ; Chun XU
Chinese Journal of Endocrine Surgery 2024;18(3):459-460
		                        		
		                        			
		                        			We will review a case of adrenal aldosterone-cortisol co-producing adenoma (A/CPA) admitted to our hospital on May 7, 2021. By reviewing the clinical courses of this case and its relevant literatures, we hope to improve the understanding and treatment level of this disease.
		                        		
		                        		
		                        		
		                        	
2.Development History and Frontier Research Progress of Pharmacokinetics of Traditional Chinese Medicine
Li-Jun ZHU ; Zhuo-Ru HE ; Cai-Yan WANG ; Dan-Yi LU ; Jun-Ling YANG ; Wei-Wei JIA ; Chen CHENG ; Yu-Tong WANG ; Liu YANG ; Zhi-Peng CHEN ; Bao-Jian WU ; Rong ZHANG ; Chuan LI ; Zhong-Qiu LIU
Journal of Guangzhou University of Traditional Chinese Medicine 2024;41(10):2746-2757
		                        		
		                        			
		                        			Pharmacokinetics of traditional Chinese medicine(TCM)is a discipline that adopts pharmacokinetic research methods and techniques under the guidance of TCM theories to elucidate the dynamic changes in the absorption,distribution,metabolism and excretion of active ingredients,active sites,single-flavour Chinese medicinal and compounded formulas of TCM in vivo.However,the sources and components of TCM are complex,and the pharmacodynamic substances and mechanisms of action of the majority of TCM are not yet clear,so the pharmacokinetic study of TCM is later than that of chemical medicines,and is far more complex than that of chemical medicines,and its development also confronts with challenges.The pharmacokinetic study of TCM originated in the 1950s and has experienced more than 70 years of development from the initial in vivo study of a single active ingredient,to the pharmacokinetic and pharmacodynamic study of active ingredients,to the pharmacokinetic study of compound and multi-component of Chinese medicine.In recent years,with the help of advanced extraction,separation and analysis technologies,gene-editing animals and cell models,multi-omics technologies,protein purification and structure analysis technologies,and artificial intelligence,etc.,the pharmacokinetics of TCM has been substantially applied in revealing and elucidating the pharmacodynamic substances and mechanisms of action of Chinese medicines,research and development of new drugs of TCM,scientific and technological upgrading of large varieties of Chinese patent medicines,as well as guiding the rational use of medicines in clinics.Pharmacokinetic studies of TCM have made remarkable breakthroughs and significant development in theory,methodology,technology and application.In this paper,the history of the development of pharmacokinetics of TCM and the progress of cutting-edge research was reviewed,with the aim of providing ideas and references for the pharmacokinetics of TCM and related research.
		                        		
		                        		
		                        		
		                        	
3.Application of ozone water injection at the site of dorsal root ganglion combined with skin lesions in acute herpes zoster lesions
Yi FANG ; Jun QIU ; Yu XU ; Yang LIU ; Qing WU ; Songhua LIU
Journal of Chinese Physician 2024;26(9):1290-1294
		                        		
		                        			
		                        			Objective:To investigate the application effect of injecting ozone water into the dorsal root ganglion combined with skin lesions in the acute stage of herpes zoster.Methods:A prospective study was conducted on 90 patients with acute lesions of herpes zoster in the chest and abdomen who were admitted to the outpatient department of Changsha Central Hospital from February 2021 to April 2024. According to the random number table method, they were divided into two groups, each with 45 cases. The control group received oral administration of famciclovir, pregabalin, weak laser skin lesion illumination, and local application of mupirocin. The observation group received 10 ml of 25 μ g/ml ozone water injected into the dorsal root ganglion under ultrasound guidance on the basis of the control group, and 20 ml of 25 μg/ml ozone water injected subcutaneously into the skin lesion. Two groups of local lesions were compared in terms of the cessation of blister growth, local scab formation, and significant pain relief time. The changes in pain Numeric Rating Scale (NRS) score and the proportion of viral inclusions in the blisters during the treatment were also analyzed. The sleep quality and quality of life scores, as well as complications during the treatment process, were analyzed after 10 days of treatment in both groups.Results:The observation group had a shorter time for the cessation of local lesion blister growth, local scab formation, and significant pain relief compared to the control group (all P<0.05). After 48 hours and 10 days of treatment, the pain NRS score of both groups was lower than before treatment (all P<0.05), and the pain NRS score of the observation group was lower than that of the control group at the same time after 48 hours and 10 days of treatment (all P<0.05). After 48 hours and 10 days of treatment, the proportion of viral inclusions in the blisters of both groups was lower than before treatment (all P<0.05), and the observation group had a lower proportion of viral inclusions in the blisters than the control group at the same time (all P<0.05). After 10 days of treatment, the sleep quality and quality of life scores of the observation group were better than those of the control group (all P<0.05). The total incidence of complications such as local infections, insomnia, palpitations, and local numbness during the treatment process of the observation group was significantly lower than that of the control group ( P<0.05). Conclusions:Subcutaneous injection of ozone water into the dorsal root ganglion and lesion site of patients with acute stage herpes zoster can inhibit the growth of local blisters, promote scab formation, reduce the level of viral inclusions in blisters, effectively alleviate patient pain, improve their sleep quality and quality of life, and reduce the occurrence of complications.
		                        		
		                        		
		                        		
		                        	
4.Quantitative Detection and Integrality Analysis of Plasma Circulating Cell-Free DNA in Multiple Myeloma
Lan-Xin ZHANG ; Yi-Zhi JIANG ; Li-Jun QIU ; Dong-Ping HUANG
Journal of Experimental Hematology 2024;32(4):1106-1111
		                        		
		                        			
		                        			Objective:To investigate the role of plasma circulating cell-free DNA(cf-DNA)in the screening and diagnosis of patients with newly diagnosed multiple myeloma(MM)and explore the changes of cf-DNA in terms of content and integrality in the assessment of disease in patients treated with chemotherapy.Methods:Peripheral blood specimens were collected from 35 newly diagnosed MM patients and 18 healthy volunteers,and 13 of the 35 patients who had finished 3 courses of standard induction chemotherapy were selected as follow-up group.The ALU247 and ALU115 fragments were used as the target genes,and the cf-DNA content in the plasma of patients and healthy controls was measured by quantitative polymerase chain reaction(qPCR).The integrality of cf-DNA was calculated by the ratio of ALU247 to ALU115.Results:Both the concentration of ALU247 and ALU115 fragments and the integrality of cf-DNA in patients were significantly higher than those in healthy controls(all P<0.05).Patients who had underwent 3 courses of induction chemotherapy had significantly decreased concentration of ALU247 and ALU115 fragments and integrality of cf-DNA after treatment(all P<0.05),and strong positive correlations were manifested between cf-DNA integrality and serum M protein content,as well as proportion of abnormal plasma cells in bone marrow before and after treatment(r=0.703,0.705).Conclusions:Cf-DNA has certain positive significance for the screening and diagnosis of MM.Furthermore,cf-DNA may be a synergism or alternative to serum M-protein content and proportion of abnormal plasma cells in bone marrow in assessing the condition,curative effect and prognosis of patients.
		                        		
		                        		
		                        		
		                        	
5.The impact of DRGs payment on Traditional Chinese Medicine hospitals:Based on difference-in-difference analysis
Hui-Jun GUO ; Jing LIU ; Guang-Yu HU ; Yi-Wei HAO ; Xin-Mei HAO ; Ya-Nan WANG ; Hui-Dong ZHU ; Qiu-Yan LI
Chinese Journal of Health Policy 2024;17(6):47-55
		                        		
		                        			
		                        			Objective:This study aims to evaluate the impact of Diagnosis-Related-Groups(DRGs)payment on the average total cost,length of stay,service volume,effectiveness,and characteristics of traditional Chinese medicine(TCM)hospitals.Methods:A national medical center specializing in TCM was selected as the research subject.The Difference-in-Difference Model(DID)was utilized to analyze the differences in various indicators between insured patients(intervention group)and uninsured patients(control group)before and after the implementation of the payment reform policy.The reliability and stability of the model were verified through parallel trend tests and placebo tests.Results:The coefficients of DID interaction terms for eleven indicators including average total hospitalization cost,number of cases,length of stay,proportion of medical service revenue,and proportion of herbal medicine revenue were significant(P<0.05).The DID interaction term coefficients for four indicators including herbal medicine usage rate and proportion of non-pharmacological TCM therapy revenue were not significant(P>0.05).Conclusion:DRG payment significantly reduced the per-admission cost,with significant decreases in consumables and medical technology expenses,optimizing cost structure,and a slight decrease in the proportion of herbal medicine costs.It is necessary to further expand the sample size,track policy impacts,and comprehensively evaluate the effects of DRG payment on TCM hospitals in China.
		                        		
		                        		
		                        		
		                        	
6.Predictive value of CD3+/CD4+T lymphocyte level and neutrophil to lymphocyte ratio in radiation pneumo-nia
The Journal of Practical Medicine 2024;40(20):2923-2928
		                        		
		                        			
		                        			Objective To investigate the predictive value of CD3+/CD4+T lymphocyte level and neutrophil to lymphocyte ratio(NLR)in radiation pneumonia.Methods The data of 87 patients with locally advanced non-operative non-small cell lung cancer admitted to our hospital from March 2018 to October 2023 were retrospectively analyzed.Among them,43 cases had radiation pneumonia and 44 cases did not have radiation pneumonia.The changes in T lymphocyte subsets and NLR before and after radiotherapy were compared between the two groups.The diagnostic value of T lymphocyte subsets and NLR in lung cancer radiation pneumonia after radiotherapy was analyzed,the correlation between T lymphocyte subsets and NLR and the grade severity of radiation pneumonia was analyzed,and the ROC curve of T lymphocyte subsets and NLR in predicting lung cancer radiation pneumonia after radiotherapy was drawn,and the AUC area was calculated.Results The levels of CD3+T lymphocytes and CD4+T lymphocytes in the post-radiotherapy group were significantly lower than those before radiotherapy and those without radiotherapy(P<0.05).The NLR in the post-radiotherapy group was significantly higher than that before radiotherapy and those without radiotherapy(P<0.05).The sensitivity,specificity,accuracy,negative pre-dictive value,and positive predictive value of the combined diagnosis of CD3+T lymphocytes,CD4+T lymphocytes,and NLR were higher than those of NLR and higher than those of CD4+T lymphocytes and CD3+T lymphocytes.The changes of CD3+T lymphocyte and CD4+T lymphocyte levels were negatively correlated with grade severity of radio-pneumonia(P<0.05),while the changes of NLR were positively correlated with grade severity of radiopneumonia(P<0.05).Combined detection of CD3+T lymphocytes,CD4+T lymphocytes,and NLR predicted that the AUC area of lung cancer after radiotherapy was 0.924,which was larger than that of CD3+T lymphocytes,CD4+T lym-phocytes,and NLR alone.Conclusion The combined detection of CD3+T lymphocytes,CD4+T lymphocytes,and NLR has an ideal value in the diagnosis and prediction of radiation pneumonia after radiotherapy for locally ad-vanced non-small cell lung cancer,and can be used as an indicator for early diagnosis and prevention of radiation pneumonia.
		                        		
		                        		
		                        		
		                        	
7.Effect of high-fat diet intake on pharmacokinetics of amoxicillin and clavulanate potassium tablet in healthy Chinese volunteers
Yu-Fang XU ; Hao-Jing SONG ; Bo QIU ; Yi-Ting HU ; Wan-Jun BAI ; Xue SUN ; Bin CAO ; Zhan-Jun DONG
The Chinese Journal of Clinical Pharmacology 2024;40(4):589-593
		                        		
		                        			
		                        			Objective To observe the pharmacokinetic effect of amoxicillin and clavulanate potassium tablets on amoxicillin in Chinese healthy subjects under fasting and high fat and high calorie diet.Methods 71 healthy subjects were given a single dose of amoxicillin potassium clavulanate tablets(0.375 g)on fasting or high fat diet,and venous blood samples were collected at different time points.The concentrations of amoxicillin in human plasma were determined by HPLC-MS/MS method,and the pharmacokinetic parameters were calculated by non-atrioventricular model using PhoenixWinNonlin 8.0 software.Results The main pharmacokinetic parameters of amoxicillin potassium clavulanate tablets after fasting and high fat diet were(5 105.00±1 444.00),(4 593.00±1 327.00)ng·mL-1,and postprandial-fasting ratio 89.40%,90%confidence interval(79.55%-100.19%);t1/2 were(1.52±0.16),(1.39±0.22)h;AUC0-t were(12 969.00±1 841.00),(11 577.00±1 663.00)ng·mL-1·h,and postdietary/fasting ratio 89.20%,90%confidence interval(83.92%-94.28%);AUC0-∞ were(13 024.00±1 846.00),(11 532.00±1 545.00)ng·mL-1·h,and postprandial-fasting ratio 88.60%,90%confidence interval(83.48%-93.50%).The median Tmax(range)were 1.63(0.75,3.00)and 2.50(0.75,6.00)h,respectively,and the Tmax of postprandial medication was delayed(P<0.01).Conclusion Compared with fasting condition,amoxicillin Tmax was significantly delayed after high fat diet,while Cmax,AUC0-t and AUC0-∞ were not significantly changed,indicating that food could delay the absorption of amoxicillin,but did not affect the degree of absorption.
		                        		
		                        		
		                        		
		                        	
8.A Core Genome Multilocus Sequence Typing Scheme for Proteus mirabilis.
Sheng Lin CHEN ; Yu Tong KANG ; Yi He LIANG ; Xiao Tong QIU ; Zhen Jun LI
Biomedical and Environmental Sciences 2023;36(4):343-352
		                        		
		                        			OBJECTIVE:
		                        			A core genome multilocus sequence typing (cgMLST) scheme to genotype and identify potential risk clonal groups (CGs) in Proteus mirabilis.
		                        		
		                        			METHODS:
		                        			In this work, we propose a publicly available cgMLST scheme for P. mirabilis using chewBBACA. In total 72 complete P. mirabilis genomes, representing the diversity of this species, were used to set up a cgMLST scheme targeting 1,842 genes, 635 unfinished (contig, chromosome, and scaffold) genomes were used for its validation.
		                        		
		                        			RESULTS:
		                        			We identified a total of 205 CGs from 695 P. mirabilis strains with regional distribution characteristics. Of these, 159 unique CGs were distributed in 16 countries. CG20 and CG3 carried large numbers of shared and unique antibiotic resistance genes. Nine virulence genes ( papC, papD, papE, papF, papG, papH, papI, papJ, and papK) related to the P fimbrial operon that cause severe urinary tract infections were only found in CG20. These CGs require attention due to potential risks.
		                        		
		                        			CONCLUSION
		                        			This research innovatively performs high-resolution molecular typing of P. mirabilis using whole-genome sequencing technology combined with a bioinformatics pipeline (chewBBACA). We found that the CGs of P. mirabilis showed regional distribution differences. We expect that our research will contribute to the establishment of cgMLST for P. mirabilis.
		                        		
		                        		
		                        		
		                        			Genome, Bacterial
		                        			;
		                        		
		                        			Proteus mirabilis/genetics*
		                        			;
		                        		
		                        			Multilocus Sequence Typing
		                        			;
		                        		
		                        			Molecular Epidemiology
		                        			;
		                        		
		                        			Genotype
		                        			
		                        		
		                        	
9.Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine.
Yi-Lun QU ; Zhe-Yi DONG ; Hai-Mei CHENG ; Qian LIU ; Qian WANG ; Hong-Tao YANG ; Yong-Hui MAO ; Ji-Jun LI ; Hong-Fang LIU ; Yan-Qiu GENG ; Wen HUANG ; Wen-Hu LIU ; Hui-di XIE ; Fei PENG ; Shuang LI ; Shuang-Shuang JIANG ; Wei-Zhen LI ; Shu-Wei DUAN ; Zhe FENG ; Wei-Guang ZHANG ; Yu-Ning LIU ; Jin-Zhou TIAN ; Xiang-Mei CHEN
Chinese journal of integrative medicine 2023;29(4):308-315
		                        		
		                        			OBJECTIVE:
		                        			To investigate the factors related to renal impairment in patients with diabetic kidney disease (DKD) from the perspective of integrated Chinese and Western medicine.
		                        		
		                        			METHODS:
		                        			Totally 492 patients with DKD in 8 Chinese hospitals from October 2017 to July 2019 were included. According to Kidney Disease Improving Global Outcomes (KDIGO) staging guidelines, patients were divided into a chronic kidney disease (CKD) 1-3 group and a CKD 4-5 group. Clinical data were collected, and logistic regression was used to analyze the factors related to different CKD stages in DKD patients.
		                        		
		                        			RESULTS:
		                        			Demographically, male was a factor related to increased CKD staging in patients with DKD (OR=3.100, P=0.002). In clinical characteristics, course of diabetes >60 months (OR=3.562, P=0.010), anemia (OR=4.176, P<0.001), hyperuricemia (OR=3.352, P<0.001), massive albuminuria (OR=4.058, P=0.002), atherosclerosis (OR=2.153, P=0.007) and blood deficiency syndrome (OR=1.945, P=0.020) were factors related to increased CKD staging in patients with DKD.
		                        		
		                        			CONCLUSIONS
		                        			Male, course of diabetes >60 months, anemia, hyperuricemia, massive proteinuria, atherosclerosis, and blood deficiency syndrome might indicate more severe degree of renal function damage in patients with DKD. (Registration No. NCT03865914).
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2
		                        			;
		                        		
		                        			Diabetic Nephropathies
		                        			;
		                        		
		                        			Hyperuricemia
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Proteinuria
		                        			;
		                        		
		                        			Renal Insufficiency, Chronic/complications*
		                        			
		                        		
		                        	
10.Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research.
Wei XU ; Shu Hua YI ; Ru FENG ; Xin WANG ; Jie JIN ; Jian Qing MI ; Kai Yang DING ; Wei YANG ; Ting NIU ; Shao Yuan WANG ; Ke Shu ZHOU ; Hong Ling PENG ; Liang HUANG ; Li Hong LIU ; Jun MA ; Jun LUO ; Li Ping SU ; Ou BAI ; Lin LIU ; Fei LI ; Peng Cheng HE ; Yun ZENG ; Da GAO ; Ming JIANG ; Ji Shi WANG ; Hong Xia YAO ; Lu Gui QIU ; Jian Yong LI
Chinese Journal of Hematology 2023;44(5):380-387
		                        		
		                        			
		                        			Objective: To understand the current status of diagnosis and treatment of chronic lymphocytic leukemia (CLL) /small lymphocytic lymphoma (SLL) among hematologists, oncologists, and lymphoma physicians from hospitals of different levels in China. Methods: This multicenter questionnaire survey was conducted from March 2021 to July 2021 and included 1,000 eligible physicians. A combination of face-to-face interviews and online questionnaire surveys was used. A standardized questionnaire regarding the composition of patients treated for CLL/SLL, disease diagnosis and prognosis evaluation, concomitant diseases, organ function evaluation, treatment selection, and Bruton tyrosine kinase (BTK) inhibitor was used. Results: ①The interviewed physicians stated that the proportion of male patients treated for CLL/SLL is higher than that of females, and the age is mainly concentrated in 61-70 years old. ②Most of the interviewed physicians conducted tests, such as bone marrow biopsies and immunohistochemistry, for patient diagnosis, in addition to the blood test. ③Only 13.7% of the interviewed physicians fully grasped the initial treatment indications recommended by the existing guidelines. ④In terms of cognition of high-risk prognostic factors, physicians' knowledge of unmutated immunoglobulin heavy-chain variable and 11q- is far inferior to that of TP53 mutation and complex karyotype, which are two high-risk prognostic factors, and only 17.1% of the interviewed physicians fully mastered CLL International Prognostic Index scoring system. ⑤Among the first-line treatment strategy, BTK inhibitors are used for different types of patients, and physicians have formed a certain understanding that BTK inhibitors should be preferentially used in patients with high-risk factors and elderly patients, but the actual use of BTK inhibitors in different types of patients is not high (31.6%-46.0%). ⑥BTK inhibitors at a reduced dose in actual clinical treatment were used by 69.0% of the physicians, and 66.8% of the physicians had interrupted the BTK inhibitor for >12 days in actual clinical treatment. The use of BTK inhibitors is reduced or interrupted mainly because of adverse reactions, such as atrial fibrillation, severe bone marrow suppression, hemorrhage, and pulmonary infection, as well as patients' payment capacity and effective disease progression control. ⑦Some differences were found in the perceptions and behaviors of hematologists and oncologists regarding the prognostic assessment of CLL/SLL, the choice of treatment options, the clinical use of BTK inhibitors, etc. Conclusion: At present, a gap remains between the diagnosis and treatment of CLL/SLL among Chinese physicians compared with the recommendations in the guidelines regarding the diagnostic criteria, treatment indications, prognosis assessment, accompanying disease assessment, treatment strategy selection, and rational BTK inhibitor use, especially the proportion of dose reduction or BTK inhibitor discontinuation due to high adverse events.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy*
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Lymphoma, B-Cell
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Immunoglobulin Heavy Chains/therapeutic use*
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail